Holen Sie sich die Stockscreener-App
20.02
2.81%
-0.60
Schlusskurs vom Vortag:
$20.62
Offen:
$20.27
24-Stunden-Volumen:
567.97K
Relative Volume:
0.52
Marktkapitalisierung:
$928.98M
Einnahmen:
$82.71M
Nettoeinkommen (Verlust:
$-102.24M
KGV:
-5.455
EPS:
-3.67
Netto-Cashflow:
$-76.57M
1W Leistung:
-0.69%
1M Leistung:
+15.17%
6M Leistung:
+74.11%
1J Leistung:
+67.98%
1-Tages-Spanne:
$20.02
$20.58
1-Wochen-Bereich:
$19.17
$21.48
52-Wochen-Spanne:
$3.42
$21.71
Urogen Pharma Ltd Stock (URGN) Company Profile
Firmenname
Urogen Pharma Ltd
Sektor
Branche
Telefon
972 9 770 7601
Adresse
9 HA'TA'ASIYA ST, RA'ANANA
Vergleichen Sie URGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
20.08 | 953.97M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.76 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.28 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.93 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.08 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-06-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-19 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2024-08-22 | Eingeleitet | Guggenheim | Buy |
| 2023-02-08 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-27 | Eingeleitet | Berenberg | Buy |
| 2020-04-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-13 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-09 | Eingeleitet | National Securities | Neutral |
| 2019-05-30 | Eingeleitet | JP Morgan | Neutral |
| 2019-05-29 | Eingeleitet | Goldman | Neutral |
| 2019-01-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-04-04 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-11-15 | Bestätigt | Oppenheimer | Outperform |
| 2017-11-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Urogen Pharma Ltd Aktie (URGN) Neueste Nachrichten
Urogen Pharma Ltd expected to post a loss of 69 cents a shareEarnings Preview - TradingView
Does UroGen Pharma Ltd. show high probability of rebound2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference - The Manila Times
Is UroGen Pharma Ltd. (UR8) stock prepared for digital transitionRate Hike & Fast Exit Strategy with Risk Control - newser.com
Why UroGen Pharma Ltd. stock could be next big winnerJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Automated trading signals detected on UroGen Pharma Ltd.Quarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
How UroGen Pharma Ltd. stock compares to industry benchmarksQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Using data tools to time your UroGen Pharma Ltd. exit2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Is UroGen Pharma Ltd. (UR8) stock worth holding before Fed meetingEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Applying Elliott Wave Theory to UroGen Pharma Ltd.July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Harel Insurance Investments & Financial Services Ltd. Has $2.16 Million Holdings in Urogen Pharma $URGN - MarketBeat
Can UroGen Pharma Ltd. stock withstand economic slowdown2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Why UroGen Pharma Ltd. (UR8) stock stays on buy listsJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Can UroGen Pharma Ltd. stock resist sector downturnsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
UroGen: Expect Rough Patch Before Strong Recovery In 2026 (NASDAQ:URGN) - Seeking Alpha
Is UroGen Pharma Ltd. stock bottoming outPortfolio Growth Summary & Community Verified Trade Signals - newser.com
How UroGen Pharma Ltd. stock reacts to job market dataJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Is UroGen Pharma Ltd. (UR8) stock undervalued after correctionMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
What indicators show strength in UroGen Pharma Ltd.Gold Moves & Safe Capital Allocation Plans - newser.com
How UroGen Pharma Ltd. (UR8) stock behaves in tightening cyclesJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
What analysts say about UroGen Pharma Ltd stockPrice Volatility Patterns & High Return Stock Ideas - earlytimes.in
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 - The Manila Times
Migdal Insurance & Financial Holdings Ltd. Reduces Position in Urogen Pharma $URGN - MarketBeat
Published on: 2025-10-30 00:50:10 - newser.com
Finanzdaten der Urogen Pharma Ltd-Aktie (URGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):